Literature DB >> 8799698

Epidemiology of late diabetic complications. A basis for the development and evaluation of preventive programs.

A S Krolewski1, J H Warram, M B Freire.   

Abstract

This article examines the relationship between duration and level of glycemia in patients with diabetes and the occurrence of complications in the eyes, kidneys, and heart. Emphasis is placed on those aspects that are relevant to the development and evaluation of preventive and therapeutic programs against these complications. Data on patients with insulin-dependent diabetes mellitus are reviewed, and the similarities and differences with the data on patients with non-insulin-dependent diabetes mellitus are discussed.

Entities:  

Mesh:

Year:  1996        PMID: 8799698     DOI: 10.1016/s0889-8529(05)70322-4

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  10 in total

1.  Hyperglycemia is independently associated with post-operative function loss in patients with primary eloquent glioblastoma.

Authors:  Thomas W Link; Graeme F Woodworth; Kaisorn L Chaichana; Stuart A Grossman; Robert S Mayer; Henry Brem; Jon D Weingart; Alfredo Quinones-Hinojosa
Journal:  J Clin Neurosci       Date:  2012-05-15       Impact factor: 1.961

Review 2.  Microalbuminuria in diabetes mellitus.

Authors:  Sheldon W Tobe; Philip Alan McFarlane; David Malcolm Naimark
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

3.  Association of Single Nucleotide Polymorphisms of Adiponectin Gene with Type 2 Diabetes Mellitus, and Their Influence on Cardiovascular Risk Markers.

Authors:  A A Momin; M P Bankar; G M Bhoite
Journal:  Indian J Clin Biochem       Date:  2016-05-05

4.  Identification of type 2 diabetes subgroups through topological analysis of patient similarity.

Authors:  Li Li; Wei-Yi Cheng; Benjamin S Glicksberg; Omri Gottesman; Ronald Tamler; Rong Chen; Erwin P Bottinger; Joel T Dudley
Journal:  Sci Transl Med       Date:  2015-10-28       Impact factor: 17.956

5.  Rationale and implementation of the SLICK project: Screening for Limb, I-Eye, Cardiovascular and Kidney (SLICK) complications in individuals with type 2 diabetes in Alberta's First Nations communities.

Authors:  Shainoor Virani; David Strong; Matthew Tennant; Mark Greve; Heather Young; Sandra Shade; Mebs Kanji; Ellen Toth
Journal:  Can J Public Health       Date:  2006 May-Jun

6.  Role of podocyte B7-1 in diabetic nephropathy.

Authors:  Paolo Fiorina; Andrea Vergani; Roberto Bassi; Monika A Niewczas; Mehmet M Altintas; Marcus G Pezzolesi; Francesca D'Addio; Melissa Chin; Sara Tezza; Moufida Ben Nasr; Deborah Mattinzoli; Masami Ikehata; Domenico Corradi; Valerie Schumacher; Lisa Buvall; Chih-Chuan Yu; Jer-Ming Chang; Stefano La Rosa; Giovanna Finzi; Anna Solini; Flavio Vincenti; Maria Pia Rastaldi; Jochen Reiser; Andrzej S Krolewski; Peter H Mundel; Mohamed H Sayegh
Journal:  J Am Soc Nephrol       Date:  2014-03-27       Impact factor: 10.121

7.  Reproductive history and hormonal birth control use are associated with coronary calcium progression in women with type 1 diabetes mellitus.

Authors:  Janet K Snell-Bergeon; Dana Dabelea; Lorraine G Ogden; John E Hokanson; Gregory L Kinney; James Ehrlich; Marian Rewers
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 8.  Recent advances in the molecular genetics of type 2 diabetes mellitus.

Authors:  Antonio Brunetti; Eusebio Chiefari; Daniela Foti
Journal:  World J Diabetes       Date:  2014-04-15

9.  The natural course of microalbuminuria among African Americans with type 2 diabetes: a 3-year study.

Authors:  Mohamed G Atta; Kesha Baptiste-Roberts; Frederick L Brancati; Tiffany L Gary
Journal:  Am J Med       Date:  2009-01       Impact factor: 4.965

Review 10.  Type 2 Diabetes Mellitus and Cardiovascular Disease: Genetic and Epigenetic Links.

Authors:  Salvatore De Rosa; Biagio Arcidiacono; Eusebio Chiefari; Antonio Brunetti; Ciro Indolfi; Daniela P Foti
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-17       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.